ACE2 Receptor‐Targeted Inhaled Nanoemulsions Inhibit SARS‐CoV‐2 and Attenuate Inflammatory Responses (Adv. Mater. 14/2024)

SARS‐CoV‐2 In article number 2311537 by Jincun Zhao, Xun Sun, and co‐workers, a specific ACE2‐binding peptide with a superior antiviral activity was identified and used to modified the inhaled nanoemulsions. The inhaled remdesivir nanoemulsions strongly inhibit SARS‐CoV‐2 not only by blocking the bi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Advanced materials (Weinheim) 2024-04, Vol.36 (14), p.n/a
Hauptverfasser:	Wang, Hairui, Luo, Shuang, Xie, Mingxin, Chen, Zhao, Zhang, Yunming, Xie, Zhiqiang, Zhang, Yongshun, Zhang, Yu, Yang, Lan, Wu, Fuhua, Chen, Xiaoyan, Du, Guangsheng, Zhao, Jincun, Sun, Xun
Format:	Artikel
Sprache:	eng
Schlagworte:	ACE2‐binding peptide Binding COVID‐19 inhalation Nanoemulsions SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!